Showing results (1481-1490 of 1,730) with videos related to
Sort By:
Pageof 173
Bulletin of Experimental Biology and Medicine|June 12, 2019
Preparation and Testing of Cells Expressing Fluorescent Proteins for Intravital Imaging of Tumor MicroenvironmentS S Vodopyanov, M A Kunin, A S Garanina, et al.Cell Reports|December 6, 2018
Development and Application of FASA, a Model for Quantifying Fatty Acid Metabolism Using Stable Isotope LabelingJoseph P Argus, Moses Q Wilks, Quan D Zhou, et al.Problemy Radiatsiinoi Medytsyny Ta Radiobiolohii|December 25, 2018
NEUROPSYCHOBIOLOGICAL MECHANISMS OF AFFECTIVE AND COGNITIVE DISORDERS IN THE CHORNOBYL CLEAN-UP WORKERS TAKING INTO ACCOUNT THE SPECIFIC GENE POLYMORPHISMSK N Loganovsky, M O Bomko, I V Abramenko, et al.Voprosy Onkologii|November 20, 2018
[New approaches to treatment for malignant tumors using perfusion technologies]A M Belyaev, G I Gafton, G S Kireeva, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|August 8, 2014
Abiraterone acetate and prednisolone for metastatic castration-resistant prostate cancer failing androgen deprivation and docetaxel-based chemotherapy: a phase II bridging study in Korean and Taiwanese patientsCheol Kwak, Tony Tong Lin Wu, Hyun Moo Lee, et al.Journal of Clinical Pharmacology|June 23, 2015
Food effects on abiraterone pharmacokinetics in healthy subjects and patients with metastatic castration-resistant prostate cancerKim N Chi, Jennifer Spratlin, Christian Kollmannsberger, et al.Journal of General Internal Medicine|December 15, 2023
Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by SexMargaret K Yu, Priya Vart, Niels Jongs, et al.Stroke (Hoboken, N.J.)|December 1, 2025
Intracranial Aneurysm Wall Phenotypes: Clinical, Morphological, and Hemodynamic InfluencesYogesh Karnam, Fernando Mut, Alexander K Yu, et al.Journal of Hazardous Materials|December 22, 2014
Surface acoustic wave ammonia sensor based on ZnO/SiO2 composite filmShuang-Yue Wang, Jin-Yi Ma, Zhi-Jie Li, et al.The Lancet. Oncology|September 15, 2018
Effect of apalutamide on health-related quality of life in patients with non-metastatic castration-resistant prostate cancer: an analysis of the SPARTAN randomised, placebo-controlled, phase 3 trialFred Saad, David Cella, Ethan Basch, et al.Pageof 173